Melphalan intraocular injection (EyePoint)

N/A

Report date: 2022/03/23 11:12:13

Base Information

Drug NameMelphalan intraocular injection (EyePoint)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agentsDNA synthesis inhibitorsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsRetinoblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPsivida
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPsivida
Active IndicationsN/A
Inactive IndicationsRetinoblastoma

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG